×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Exploring Regulator Career Paths: The Impact of Diversity on Decision Making and Medicines Development
Session Chair(s)
Paula Walker, MA
Global Head of Risk Based Quality Management
Roche Products Ltd., United Kingdom
Diversity in clinical trials is a widely discussed topic, but have you considered how diversity in career journeys influences decision making within regulatory bodies? Join us to hear from our panel about the impact of their varied career paths.
Learning Objective : Understand how diversity within regulators supports medicines development for patients and society; Explore how skills developed in one sector (e.g., industry, academia, healthcare) can contribute to the skills needed in another (e.g., regulators); Examine how diversity in recruitment and career pathways supports diversity in decision making in medicines development.
Speaker(s)
FDA Career Pathway: Impact to Medicines Development
Representative Invited
FDA, United States
Health Canada Career Pathway: Impact to Medicines Development
Representative Invited
Health Canada, Canada
MHRA Career Pathway: Impact to Medicines Development
Representative Invited
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Have an account?